Nomura Asset Capital Corporation v. Cadwalader, Wickersham & Taft

41 N.E.3d 353, 26 N.Y.3d 40, 19 N.Y.S.3d 488
CourtNew York Court of Appeals
DecidedOctober 22, 2015
Docket122
StatusPublished
Cited by55 cases

This text of 41 N.E.3d 353 (Nomura Asset Capital Corporation v. Cadwalader, Wickersham & Taft) is published on Counsel Stack Legal Research, covering New York Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nomura Asset Capital Corporation v. Cadwalader, Wickersham & Taft, 41 N.E.3d 353, 26 N.Y.3d 40, 19 N.Y.S.3d 488 (N.Y. 2015).

Opinion

OPINION OF THE COURT

Rivera, J.

On these cross appeals from an order granting partial summary judgment in a legal malpractice action, we conclude that no triable issues of fact exist with respect to the first cause of action, which alleges that counsel failed to properly advise and conduct requisite due diligence in a mortgage securitization matter. Therefore, we modify the Appellate Division order, grant summary judgment to dismiss the first cause of action in its entirety, and otherwise affirm.

L

At times relevant to this appeal, plaintiffs, Nomura Asset Capital Corporation and Asset Securitization Corporation (Nomura), and defendant, the law firm of Cadwalader, Wicker-sham & Taft LLP, were working in the mortgage securitization field. In this industry, an investment bank sources and funds mortgages on properties with the objective of aggregating the mortgages into securitization pools. The loans are then sold to a trust, which issues securities in the form of certificates to investors. The certificates entitle the holders to a portion of the revenue stream produced by payments made by the mortgage borrowers. 1

Nomura established a commercial mortgage-backed securities business, 2 and engaged Cadwalader to advise and confirm that Nomura’s securitized commercial mortgage loans qualified *44 as real estate mortgage investment conduit (REMIC) trusts. 3 Over the course of several years, Cadwalader’s work on Nomura REMIC securitizations garnered immense profits for Nomura and significant legal fees for Cadwalader. However, the professional relationship soured when a 1997 REMIC securitization, known as the series 1997-D5 securitization (D5 securitization), embroiled Nomura in federal litigation and demands for a buyback of a defaulted loan. In an attempt to recoup its losses associated with the federal lawsuit, Nomura commenced the underlying legal malpractice action against Cadwalader, alleging that Cadwalader failed to provide appropriate legal advice and perform necessary due diligence concerning the REMIC eligibility of the D5 securitization.

Now, almost two decades since the events leading to the original securitization, and almost 10 years since Nomura filed this action, the case has reached this Court, and we are presented with the question whether Cadwalader is entitled to summary judgment as to all or part of the first cause of action. For the reasons set forth below, we conclude that Cadwalader has established, as a matter of law, that summary judgment and dismissal of the legal malpractice cause of action are merited in this case.

IL

We begin our analysis with a discussion of the relevant legal requirements for REMIC qualification of the D5 securitization, and the events leading up to Cadwalader’s opinion as to the REMIC eligibility of the mortgage loan at the center of the parties’ dispute. The D5 securitization consists of 156 loans, secured by first liens on 220 commercial and multifamily properties. For these mortgage loans to be pooled in a REMICqualified trust they had to be in compliance with certain federal Internal Revenue Code requirements, including that substantially all of the assets be “qualified mortgages and permitted investments” within the meaning of the Code (26 USC § 860D [a] [4]).

Under the Internal Revenue Code, a “qualified mortgage” is “principally secured by an interest in real property” (26 USC § 860G [a] [3] [A]), which in accordance with federal tax regula *45 tions, requires that “the fair market value of the interest in real property securing” the mortgage is “at least equal to 80 percent of the adjusted issue price” of the loan, as of the loan origination date or when the REMIC sponsor contributes the loan to the trust (26 CFR 1.860G-2 [a] [1] [i]; [5]). This is known as the “80% test.”

Although pursuant to the federal regulations the 80% test is based on a value-to-loan ratio (VTL) (see 26 CFR 1.860G-2 [a] [1] [i]; [5]), the parties agree that mortgage lenders, such as Nomura, typically utilize a loan-to-value ratio (LTV) for underwriting purposes, and that Nomura understood that an 80% VTL is equal to a 125% LTV. 4 However, the LTV is based on the overall value of property, whereas the regulations define REMIC real property as “land or improvements thereon, such as buildings or other inherently permanent structures” (26 CFR 1.856-3 [d]). It does not include personal property (id.).

One of the mortgages included in the D5 trust was a $50 million loan secured by the Doctor’s Hospital of Hyde Park (hospital), an acute care facility located in Chicago. In order to be REMIC-qualified and in compliance with the warranties set forth in the pooling service agreement (PSA) and mortgage loan purchase and sale agreement (MLPSA), the real property value for the hospital had to be appraised at a minimum of $40 million. 5 Nomura’s appraiser estimated the hospital property’s market value at $68 million, based on a valuation of $3 million for the land, $27,960,000 for improvements, $9,640,000 for equipment, and $27,400,000 for intangibles. Although not set forth in the appraisal, a property valued at $68 million with a $50 million mortgage has an LTV of 73%, and therefore appears to be REMIC-qualified.

The final appraisal was determined after a reconciliation of three valuation approaches: “income capitalization,” “sales comparison,” and “cost.” The “income capitalization approach” resulted in an estimated valuation of the hospital property at $68 million, based on a 21.5% capitalization rate of the *46 hospital’s net operating income ($14,547,499), determined by gross annual income, minus operating expenses. The “sales comparison” resulted in an estimated value of $64 million, based on the cost of acquiring an equally desirable substitute property. The “cost approach” estimated the property at $40.6 million, based on the value of the land as vacant ($3 million), replacement costs of buildings ($27,761,163), and depreciation of improvements and equipment ($180,000 and $9,640,000, respectively).

The appraisal lacked a detailed breakdown of the hospital equipment included in the property valuation, and instead applied figures for similar acute care hospitals. However, because not all types of equipment count for REMIC purposes, the lack of detail arguably left unclear whether the appraisal could provide a reasonable basis for determining REMIC qualification. Although the land, building, and improvements, valued by the appraiser at $30,960,000, would count under the RE-MIC standards, they failed to meet the $40 million minimum required under the 80% test. Nevertheless, Nomura relied on this appraisal, as written.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Losurdo v. Tutor Perini Corp.
2026 NY Slip Op 30888(U) (New York Supreme Court, New York County, 2026)
Sathyanarayanan v. Moberg
2026 NY Slip Op 50237(U) (New York Supreme Court, Suffolk County, 2026)
36th HY LLC v. Yan Rong Zhen
2026 NY Slip Op 30702(U) (New York Supreme Court, New York County, 2026)
PCO 1500 Inv., L.P. v. Ahmuty, Demers & McManus
2026 NY Slip Op 30664(U) (New York Supreme Court, New York County, 2026)
Wilmington Sav. Fund Socy., FSB v. Decatur 1147 LLC
2025 NY Slip Op 34398(U) (New York Supreme Court, Kings County, 2025)
Saracino v. Rosenberg, Calica & Birney, LLP
2025 NY Slip Op 06205 (Appellate Division of the Supreme Court of New York, 2025)
Stinnett v. Derek Smith Law Group, PLLC
2025 NY Slip Op 04677 (Appellate Division of the Supreme Court of New York, 2025)
Shustik v. 303 W. 116 St. LLC
2025 NY Slip Op 32468(U) (New York Supreme Court, New York County, 2025)
Kaufman v. Starbucks Corp.
2025 NY Slip Op 31614(U) (New York Supreme Court, New York County, 2025)
99th Ave. Holdings, LLC v. Schatz
2025 NY Slip Op 30979(U) (New York Supreme Court, New York County, 2025)
Kliger-Weiss Infosystems, Inc. v. Ruskin Moscou Faltischek, P.C.
2025 NY Slip Op 00956 (Appellate Division of the Supreme Court of New York, 2025)
Amici v. Mazza
2025 NY Slip Op 00259 (Appellate Division of the Supreme Court of New York, 2025)
D'Angelo v. Kujawski
2024 NY Slip Op 05200 (Appellate Division of the Supreme Court of New York, 2024)
558 Seventh Ave Corp. v. Times Sq Photo, Inc.
2024 NY Slip Op 33273(U) (New York Supreme Court, New York County, 2024)
iQuanti, Inc. v. RTW Retailwinds Acquistion LLC
2024 NY Slip Op 33169(U) (New York Supreme Court, New York County, 2024)
FTF Lending, LLC v. Mavrides, Moyal, Packman & Sadkin, LLP
2024 NY Slip Op 33115(U) (New York Supreme Court, New York County, 2024)
Country-Wide Ins. Co. v. Alvarez
2024 NY Slip Op 32874(U) (New York Supreme Court, New York County, 2024)
Chao v. Burges
2024 NY Slip Op 32590(U) (New York Supreme Court, New York County, 2024)
Wohnberger v. Lucani
2024 NY Slip Op 31945(U) (New York Supreme Court, New York County, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
41 N.E.3d 353, 26 N.Y.3d 40, 19 N.Y.S.3d 488, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nomura-asset-capital-corporation-v-cadwalader-wickersham-taft-ny-2015.